The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease

European Respiratory Review

Volumn 19, Issue 117, 2010, Pages 237-241

  Wells, A U ^a  

^a NONE   (United Kingdom)

Author keywords

Bronchoalveolar lavage; Diffuse parenchymal lung disease; Interstitial lung disease

Indexed keywords

ALLERGIC PNEUMONITIS; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE PARENCHYMAL LUNG DISEASE; DISEASE CLASSIFICATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTOSIS; MEDICAL LITERATURE; NEUTROPHILIA; OPPORTUNISTIC INFECTION; PROGNOSIS; REVIEW; TREATMENT INDICATION;

ALGORITHMS; BRONCHOALVEOLAR LAVAGE; HUMANS; LUNG DISEASES, INTERSTITIAL;

EID: 78449269444     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00005510     Document Type: Review

References (35)

1. Klech H, Hutter C. Clinical guidelines and indications for bronchoalveolar lavage (BAL). Report of the European Society of Pneumonology Task Group on BAL. Eur Respir J 1990; 3: 937-974.
2. The BAL Cooperative Group Steering Committee: bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990; 141: S169-S202.
3. Joint American Thoracic Society and European Respiratory Society Group. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664.
4. Joint American Thoracic Society and European Respiratory Society Group. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
5. Davison AG, Heard BE, McAllister WAC, et al. Cryptogenic organizing pneumonia. Q J Med 1983; 52: 382-394.
6. Ward K, O'Connor C, Odium C, et al. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease progression. Thorax 1989; 44: 6-12.
7. Drent M, Jacobs JA, de Vries J, et al. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999; 13: 1338-1344.
8. Drent M, van Nierop MA, Gerritsen FA, et al. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996; 153: 736-741.
9. Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008; 177: 1338-1347.
10. Nagai S, Kitaicha M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12: 1010-1019.
11. Park JS, Lee KS, Kim JS, et al. NSIP with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645-648.
12. Veeraraghavan S, Latsi PI, Wells AU, et al. Bronchoalveolar lavage findings in idiopathic UIP and NSIP. Eur Respir J 2003; 22: 239-244.
13. Wells AU. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med 2001; 22: 449-450.
14. Drent M, van Velzen-Blad H, Diamant M, et al. Relationship between presentation of sarcoidosis and T lymphocyte profile: a study in bronchoalveolar lavage fluid. Chest 1993; 104: 795-800.
15. Drent M, van Velzen-Blad H, Diamant M, et al. Differential diagnostic value of plasma cells in bronchoalveolar lavage fluid. Chest 1993; 103: 1720-1734.
16. Drent M, Grutters JC, Mulder PG, et al. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile? Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 31-38.
17. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001; 7: 255-261.
18. Kantrow SP, Meyer KC, Kidd P, et al. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997; 10: 2716-2721.
19. Aziz ZA, Wells AU, Bateman ED, et al. Clinical decision-making in interstitial lung disease: effect of thin-section CT. Radiology 2006; 238: 725-733.
20. Welker L, Jones RA, Costabel U, et al. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2003; 24: 1000-1006.
21. Kinder BW, Wells AU. The art and science of diagnosing interstitial lung diseases. Am J respir Crit Care Med 2009; 179: 974-975.
22. Oshimo S, Bonella F, Cui A, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am Rev Respir Dis 2009; 179: 1043-1047.
23. Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005; 60: 665-671.
24. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135: 696-704.
25. Boomars KA, Wagenaar SS, Mulder PGH, et al. Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. Thorax 1995; 50: 1087-1092.
26. White B, Moore WC, Wigley FM, et al. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000; 132: 947-954.
27. Silver RM, Miller KS, Kinsella MB, et al. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 1990; 88: 470-476.
28. Wells AU, Hansell DM, Haslam PL, et al. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 1998; 157: 1474-1482.
29. Kinder BW, Brown KK, Schwarz MI, et al. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 2008; 133: 226-232.
30. Wells AU, Hansell DM, Rubens MB, et al. Fibrosing alveolitis in systemic sclerosis: bronchoalveolar lavage findings in relation to computed tomographic appearances. Am J Respir Crit Care Med 1994; 150: 462-468.
31. Goh NS, Veeraraghavan S, Desai SR, et al. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 2007; 56: 2005-2012.
32. Strange C, Bolster MB, Roth MD, et al. Scleroderma Lung Study Research Group. Bronchoalveolar lavage and response to cyclo-phosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 2008; 177: 91-98.
33. Martin RJ, Coalson JJ, Rogers RM, et al. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 1980; 121: 819-825.
34. Betsuyaku T, Munakata M, Yamaguchi S, et al. Establishing diagnosis of pulmonary malignant lymphoma by gene rearrangement analysis of lymphocytes in bronchoalveolar lavage fluid. Am Rev Respir Dis 1994; 149: 526-529.
35. Baughman RP. Use of bronchoscopy in the diagnosis of infection in the immunocompromised host. Thorax 1994; 49: 3-7.